Abstract:IntroductionNon-small cell lung cancer (NSCLC) constitutes 85 percent of lung cancer diagnoses and poses an economic threat to the sustainability of healthcare services. This study was conducted to estimate hospitalization costs associated with advanced NSCLC without sensitizing EGFR (epidermal growth factor receptor) and ALK (anaplastic lymphoma kinase) alterations in China and explore the potential predictors.MethodsData linked with patients with advanced NSCLC (stage IIIB–IV) without sensitizing EGFR and ALK alterations were obtained from the electronic medical record system of one general hospital and one cancer hospital in Jiangsu province, China, ranging from January 2017 to December 2020. We excluded patients with lung metastases from tumors elsewhere in the body. The socio-demographic characteristics, disease-related characteristics, and hospitalization cost of eligible patients were extracted. We used the generalized linear model (GLM) to assess the potential influencing factors of hospitalization cost.ResultsPatients with advanced NSCLC (n=7,260) were included in this study. The median hospitalization cost of advanced NSCLC was USD11,540.47. The median hospitalization examination and test costs were USD1,539.46, and the median hospitalization drug cost was USD6,351.47. GLM results showed that patients aged 60 or older (95% Confidence Interval [CI]: -1019.1,128.6), who had no gene driver (95%CI: -1,681.6,-233.6) were more likely to have relatively lower hospitalization costs for advanced NSCLC. Patients treated in cancer hospital (95%CI: 1,329.1,2,620.0) and with non-squamous carcinoma (95%CI: 171.3, 1,235.4) may have higher hospitalization costs. Compared with Urban Employee Basic Medical Insurance, patients with free medical services (95%CI: 1,248.4,6,298.7) were associated with higher hospitalization costs. Patients with higher hospitalization frequency and longer length of hospital stay (p < 0.05) were linked to higher hospitalization costs.ConclusionsThe hospitalization costs linked to advanced NSCLC is considerable for patients, with drug costs accounting for the largest. More efforts still need to be made to alleviate the direct medical burden.

The influencing factors of the hospitalization expenses of five kinds of patients with malignant tumor in Jiangsu province

Analysis on Hospitalization Expense of Five Kinds of Cancers and Its Influencing Factors

Analysis of the composition and influencing factors of hospitalization expenses for 1517 patients with lung malignant tumors in Beijing

Analysis of direct medical costs and their influencing factors for in-patients with Multiple Mye-loma:Based on the reimbursement claim database in Guangzhou, China

Analysis of hospitalization expenses and influencing factors for elderly cancer patients in a tertiary hospital in Dalian, China: a five‐year retrospective study

Study on hospitalization expenses of elderly patients with lung cancer in the Western region of China

Factors Influencing the Expenditure of Medical Insurance Inpatient

PCN43 STUDY ON MEDICAL EXPENDITURE AND PAYMENT PATTERNS OF INSURED PATIENTS WITH CANCER IN CHINA

Analysis of Factors Influencing Hospitalization Expenses of Patients With Gastric Cancer in Shanghai, 2014-2021: Based on Grey Relational Analysis and Structural Equation Modeling

Pathway Analysis of Hospitalization Expense Influencing Factors of 6168 Liver Cancer Patients

Influencing Factor Hospitalization Expenses in Patients Undergone Transsphenoidal Pituitary Tumor Resection

Discussions on the medical expenses of colorectal cancer based on clinical pathway

Impact of the Fee-for-service Payment Method of Urban Basic Health Insurance on Treatment Expenses of Insured Patients with Cancer in China

Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China

Absence of appropriate hospitalization cost control for patients with medical insurance: a comparative analysis study.

Influencing factors of hospitalization cost of hypertension patients in traditional Chinese medicine hospitals

Grey Correlation Analysis on Influencing Factors of Hospitalization Cost in Patients Undergone Unilateral Breast Modified Radical Mastectomy

A Survey of HospitalizationCost and Implementation for Health Insurance Policy at the Department of General Surgery Among General Hospitals

PP71 Hospitalization Costs Associated with Advanced Non-Small Cell Lung Cancer in China: Real World Evidence from Jiangsu

Direct Inpatient Costs and Influencing Factors for Patients with Rectal Cancer with Low Anterior Resection: a Retrospective Observational Study at a Three-Tertiary Hospital in Beijing, China

TREND ANALYSIS OF HOSPITALIZATION COST OVER OVARIAN CANCER IN LANZHOU FROM 1996 TO 2006